Exact Sciences Corp at JPMorgan Healthcare Conference Transcript
Hello. Thank you, everyone, for coming today. It's my pleasure to introduce Exact Sciences. Today, we'll be joined by Kevin Conroy, who's the Chairman and the CEO of the company, who will be providing the presentation. And then we will also be joined by Jeff Elliott, who is the CFO and COO; and Everett Cunningham, who's the CCO for Q&A. Handing it over. Thank you.
Thank you, Zach. Thanks JPMorgan for having us attend and present and to all those on the webcast and here, thanks for joining. We will be making forward-looking statements. This is our safe harbor statement. Remember these numbers, 1, 5, 7, 9, 14 and 10 million.
In 2009, I had a meeting that changed everything. I got a call from the Exact Sciences Board. They were looking for a CEO to effectively restart the company and develop a non-invasive colon cancer screening test. And the only problem is they had no R&D team left after a decade of work and no real proof of concept. So they suggested
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |